BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23518657)

  • 1. Germination efficiency of clinical Clostridium difficile spores and correlation with ribotype, disease severity and therapy failure.
    Moore P; Kyne L; Martin A; Solomon K
    J Med Microbiol; 2013 Sep; 62(Pt 9):1405-1413. PubMed ID: 23518657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in silico evaluation of treatment regimens for recurrent Clostridium difficile infection.
    Blanco N; Foxman B; Malani AN; Zhang M; Walk S; Rickard AH; Eisenberg MC
    PLoS One; 2017; 12(8):e0182815. PubMed ID: 28800598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of relapsing Clostridium difficile infections do not correlate with virulence-, spore- and vegetative cell-associated phenotypes.
    Plaza-Garrido Á; Miranda-Cárdenas C; Castro-Córdova P; Olguín-Araneda V; Cofré-Araneda G; Hernández-Rocha C; Carman R; Ibáñez P; Fawley WN; Wilcox MH; Gil F; Calderón IL; Fuentes JA; Guzmán-Durán AM; Alvarez-Lobos M; Paredes-Sabja D
    Anaerobe; 2015 Dec; 36():30-8. PubMed ID: 26403333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates.
    Tijerina-Rodríguez L; Villarreal-Treviño L; Baines SD; Morfín-Otero R; Camacho-Ortíz A; Flores-Treviño S; Maldonado-Garza H; Rodríguez-Noriega E; Garza-González E
    PLoS One; 2019; 14(7):e0220671. PubMed ID: 31365590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effect of oritavancin on Clostridium difficile spore germination, outgrowth and recovery.
    Chilton CH; Freeman J; Baines SD; Crowther GS; Nicholson S; Wilcox MH
    J Antimicrob Chemother; 2013 Sep; 68(9):2078-82. PubMed ID: 23759507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal calcium and bile salts facilitate germination of Clostridium difficile spores.
    Kochan TJ; Somers MJ; Kaiser AM; Shoshiev MS; Hagan AK; Hastie JL; Giordano NP; Smith AD; Schubert AM; Carlson PE; Hanna PC
    PLoS Pathog; 2017 Jul; 13(7):e1006443. PubMed ID: 28704538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model.
    Freeman J; Marquis M; Crowther GS; Todhunter SL; Fawley WN; Chilton CH; Moeck G; Lehoux D; Wilcox MH
    J Antimicrob Chemother; 2012 Dec; 67(12):2919-26. PubMed ID: 22899803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, epidemiological and microbiological characteristics of relapse and re-infection in Clostridium difficile infection.
    Gómez S; Chaves F; Orellana MA
    Anaerobe; 2017 Dec; 48():147-151. PubMed ID: 28830842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characteristics of Clostridium difficile strains from patients with a first recurrence more than 8 weeks after the primary infection.
    Chen Y; Rashid MU; Huang H; Fang H; Nord CE; Wang M; Weintraub A
    J Microbiol Immunol Infect; 2017 Aug; 50(4):532-536. PubMed ID: 26698688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination of the probiotic and prebiotic product can prevent the germination of Clostridium difficile spores and infection.
    Rätsep M; Kõljalg S; Sepp E; Smidt I; Truusalu K; Songisepp E; Stsepetova J; Naaber P; Mikelsaar RH; Mikelsaar M
    Anaerobe; 2017 Oct; 47():94-103. PubMed ID: 28465256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics.
    van Beurden YH; Nezami S; Mulder CJJ; Vandenbroucke-Grauls CMJE
    Clin Microbiol Infect; 2018 Jan; 24(1):85.e1-85.e4. PubMed ID: 28782647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection.
    Peretz A; Tkhawkho L; Pastukh N; Brodsky D; Halevi CN; Nitzan O
    BMC Infect Dis; 2016 Jun; 16():309. PubMed ID: 27334992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolating and Purifying Clostridium difficile Spores.
    Edwards AN; McBride SM
    Methods Mol Biol; 2016; 1476():117-28. PubMed ID: 27507337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Clostridium difficile-Specific, Gel-Forming Protein Required for Optimal Spore Germination.
    Donnelly ML; Li W; Li YQ; Hinkel L; Setlow P; Shen A
    mBio; 2017 Jan; 8(1):. PubMed ID: 28096487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new strategy for the prevention of Clostridium difficile infection.
    Howerton A; Patra M; Abel-Santos E
    J Infect Dis; 2013 May; 207(10):1498-504. PubMed ID: 23420906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of early stages of Clostridium difficile infection: germination and colonization.
    Sarker MR; Paredes-Sabja D
    Future Microbiol; 2012 Aug; 7(8):933-43. PubMed ID: 22913353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reexamining the Germination Phenotypes of Several Clostridium difficile Strains Suggests Another Role for the CspC Germinant Receptor.
    Bhattacharjee D; Francis MB; Ding X; McAllister KN; Shrestha R; Sorg JA
    J Bacteriol; 2015 Dec; 198(5):777-86. PubMed ID: 26668265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile ribotype 176 - A predictor for high mortality and risk of nosocomial spread?
    Polivkova S; Krutova M; Petrlova K; Benes J; Nyc O
    Anaerobe; 2016 Aug; 40():35-40. PubMed ID: 27155489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High morbidity and mortality of Clostridium difficile infection and its associations with ribotype 002 in Hong Kong.
    Wong SH; Ip M; Hawkey PM; Lo N; Hardy K; Manzoor S; Hui WW; Choi KW; Wong RY; Yung IM; Cheung CS; Lam KL; Kwong T; Wu WK; Ng SC; Wu JC; Sung JJ; Lee N
    J Infect; 2016 Aug; 73(2):115-22. PubMed ID: 27246801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The characteristics of Clostridium difficile ST81, a new PCR ribotype of toxin A- B+ strain with high-level fluoroquinolones resistance and higher sporulation ability than ST37/PCR ribotype 017.
    Wang B; Peng W; Zhang P; Su J
    FEMS Microbiol Lett; 2018 Sep; 365(17):. PubMed ID: 30085003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.